Regulation of permeability barrier homeostasis

Clinics in Dermatology

Volumn 30, Issue 3, 2012, Pages 263-268

  Feingold, Kenneth R ^a   Denda, Mitsuhiro ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYTOKINE; GLUCOCORTICOID; GROWTH FACTOR; LIVER X RECEPTOR; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; SKIN LIPID; TESTOSTERONE; VITAMIN D; VITAMIN D RECEPTOR;

ACIDIFICATION; CALCIUM METABOLISM; CALCIUM TRANSPORT; CELL SECRETION; CUTANEOUS PARAMETERS; CYTOKINE PRODUCTION; EPIDERMIS; EPIDERMIS GRANULAR LAYER; EXTRACELLULAR SPACE; HOMEOSTASIS; HORMONE ACTION; HUMAN; KERATINOCYTE; LAMELLAR BODY; LIPOGENESIS; METABOLIC REGULATION; NONHUMAN; NOTE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SKIN FUNCTION; SKIN PH; STRATUM CORNEUM;

CALCIUM; CYTOKINES; EPIDERMIS; HOMEOSTASIS; HUMANS; KERATINOCYTES; NITRIC OXIDE; PERMEABILITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SKIN ABSORPTION;

EID: 84859771433     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.08.008     Document Type: Note

References (57)

1. Elias P.M. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005, 125:183-200.
2. Feingold K.R. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007, 48:2531-2546.
3. Elias P.M., Schmuth M., Uchida Y., et al. Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol 2002, 11:248-256.
4. Schmuth M., Fluhr J.W., Crumrine D.C., et al. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol 2004, 122:909-922.
5. Taljebini M., Warren R., Mao-Oiang M., Lane E., Elias P.M., Feingold K.R. Cutaneous permeability barrier repair following various types of insults: kinetics and effects of occlusion. Skin Pharmacol 1996, 9:111-119.
6. Yang L., Mao-Qiang M., Taljebini M., Elias P.M., Feingold K.R. Topical stratum corneum lipids accelerate barrier repair after tape stripping, solvent treatment and some but not all types of detergent treatment. Br J Dermatol 1995, 133:679-685.
7. Ghadially R., Brown B.E., Sequeira-Martin S.M., Feingold K.R., Elias P.M. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 1995, 95:2281-2290.
8. Jiang Y.J., Lu B., Kim P., Elias P.M., Feingold K.R. Regulation of ABCA1 expression in human keratinocytes and murine epidermis. J Lipid Res 2006, 47:2248-2258.
9. Menon G.K., Grayson S., Elias P.M. Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 1985, 84:508-512.
10. Lee S.H., Elias P.M., Proksch E., Menon G.K., Mao-Quiang M., Feingold K.R. Calcium and potassium are important regulators of barrier homeostasis in 26.murine epidermis. J Clin Invest 1992, 89:530-538.
11. Menon G.K., Elias P.M., Lee S.H., Feingold K.R. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tissue Res 1992, 270:503-512.
12. Mao-Qiang M., Mauro T., Bench G., Mao-Qiang M., Mauro T., Bench G. Calcium and potassium inhibit barrier recovery after disruption, independent of the type of insult in hairless mice. Exp Dermatol 1997, 6:36-40.
13. Lee S.H., Choi E.H., Feingold K.R., Jiang S., Ahn S.K. Iontophoresis itself on hairless mouse skin induces the loss of the epidermal calcium gradient without skin barrier impairment. J Invest Dermatol 1998, 111:39-43.
14. Menon G.K., Price L.F., Bommannan B., Elias P.M., Feingold K.R. Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol 1994, 102:789-795.
15. Lee S.H., Elias P.M., Feingold K.R., et al. A role for ions in barrier recovery after acute perturbation. J Invest Dermatol 1998, 111:39-43.
16. Elias P., Ahn S., Brown B., Crumrine D., Feingold K.R. Origin of the epidermal calcium gradient: regulation by barrier status and role of active vs passive mechanisms. J Invest Dermatol 2002, 119:1269-1274.
17. Menon G.K., Elias P.M., Feingold K.R. Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient. Br J Dermatol 1994, 130:139-147.
18. Elias P.M., Nau P., Hanley K., et al. Formation of the epidermal calcium gradient coincides with key milestones of barrier ontogenesis in the rodent. J Invest Dermatol 1998, 110:399-404.
19. Wood L.C., Jackson S.M., Elias P.M., Grunfeld C., Feingold K.R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992, 90:482-487.
20. Wood L.C., Stalder A.K., Liou A., et al. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol 1997, 6:98-104.
21. Jensen J.M., Schutze S., Förl M., Krönke M., Proksch E. Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 1999, 104:1761-1770.
22. Wang X.P., Schunck M., Kallen K.J., et al. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 2004, 123:124-131.
23. Barland C.O., Zettersten E., Brown B.S., Ye J., Elias P.M., Ghadially R. Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol 2004, 122:330-336.
24. Hardardottir I., Kunitake S.T., Moser A.H., et al. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters. J Clin Invest 1994, 94:1304-1309.
25. Elias P.M., Arbiser J., Brown B.E., et al. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am J Pathol 2008, 173:689-699.
26. Liou A., Elias P.M., Grunfeld C., Feingold K.R., Wood L.C. Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. J Invest Dermatol 1997, 108:73-77.
27. Schmuth M., Jiang Y.J., Dubrac S., Elias P.M., Feingold K.R. Thematic review series: skin lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology. J Lipid Res 2008, 49:499-509.
28. Man M.Q., Choi E.H., Schmuth M., et al. Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing. J Invest Dermatol 2006, 126:386-392.
29. Jiang Y.J., Lu B., Kim P., et al. PPAR and LXR activators regulate ABCA12 expression in human keratinocytes. J Invest Dermatol 2008, 128:104-109.
30. Man M.Q., Barish G.D., Schmuth M., et al. Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation. J Invest Dermatol 2008, 128:370-377.
31. Bikle D.D., Chang S., Crumrine D., et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 2004, 122:984-992.
32. Oda Y., Uchida Y., Moradian S., Crumrine D., Elias P.M., Bikle D.D., Vitamin D. receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol 2009, 129:1367-1378.
33. Ashida Y., Denda M., Hirao T. Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 2001, 116:261-265.
34. Denda M., Fuziwara S., Inoue K. Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2003, 121:142-148.
35. Denda M., Fuziwara S., Inoue K. Influx of calcium and chloride ions into epidermal keratinocytes regulates exocytosis of epidermal lamellar bodies and skin permeability barrier homeostasis. J Invest Dermatol 2003, 121:362-367.
36. Denda M., Inoue K., Inomata S., Denda S. gamma-Aminobutyric acid (A) receptor agonists accelerate cutaneous barrier recovery and prevent epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2002, 119:1041-1047.
37. Denda M., Nakatani M., Ikeyama K., Tsutsumi M., Denda S. Epidermal keratinocytes as the forefront of the sensory system. Exp Dermatol 2007, 16:157-161.
38. Denda M., Sokabe T., Fukumi-Tominaga T., Tominaga M. Effects of skin surface temperature on epidermal permeability barrier homeostasis. J Invest Dermatol 2007, 127:654-659.
39. Denda M., Tsutsumi M., Denda S. Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis. Exp Dermatol 2010, 19:791-795.
40. Denda S., Denda M., Inoue K., Hibino T. Glycolic acid induces keratinocyte proliferation in a skin equivalent model via TRPV1 activation. J Dermatol Sci 2010, 57:108-113.
41. Fuziwara S., Inoue K., Denda M. NMDA-type glutamate receptor is associated with cutaneous barrier homeostasis. J Invest Dermatol 2003, 120:1023-1029.
42. Fuziwara S., Suzuki A., Inoue K., Denda M. Dopamine D2-like receptor agonists accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2005, 125:783-789.
43. Ikeyama K., Denda M. Effect of endothelial nitric oxide synthase on epidermal permeability barrier recovery after disruption. Br J Dermatol 2010, 163:915-919.
44. Ikeyama K., Denda S., Tsutsumi M., Denda M. Neuronal nitric oxide synthase in epidermis is involved in cutaneous circulatory response to mechanical stimulation. J Invest Dermatol 2010, 130:1158-1166.
45. Ikeyama K., Fuziwara S., Denda M. Topical application of neuronal nitric oxide synthase inhibitor accelerates cutaneous barrier recovery and prevents epidermal hyperplasia induced by barrier disruption. J Invest Dermatol 2007, 127:1713-1719.
46. Hachem J.P., Houben E., Crumrine D., et al. Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol 2006, 126:2074-2086.
47. Denda M., Kitamura K., Elias P.M., Feingold K.R. trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol 1997, 109:84-90.
48. Hachem J.P., Crumrine D., Fluhr J., Brown B.E., Feingold K.R., Elias P.M. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003, 121:345-353.
49. Hachem J.P., Man M.Q., Crumrine D., et al. Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005, 125:510-520.
50. Demerjian M., Hachem J.P., Tschachler E., et al. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 2008, 172:86-97.
51. Sheu H.M., Lee J.Y., Chai C.Y., Kuo K.W. Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 1997, 136:884-890.
52. Sheu H.M., Lee J.Y., Kuo K.W., Tsai J.C. Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography. J Dermatol 1998, 25:281-289.
53. Kao J.S., Fluhr J.W., Man M.Q., et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003, 120:456-464.
54. Choi E.H., Demerjian M., Crumrine D., et al. Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1657-R1662.
55. Denda M., Tsuchiya T., Elias P.M., Feingold K.R. Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 2000, 278:R367-R372.
56. Kao J.S., Garg A., Mao-Qiang M., et al. Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 2001, 116:443-451.
57. Tsutsumi M., Denda M. Paradoxical effects of beta-estradiol on epidermal permeability barrier homeostasis. Br J Dermatol 2007, 157:776-779.